Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 23;26(4):106492.
doi: 10.1016/j.isci.2023.106492. eCollection 2023 Apr 21.

Structure-affinity and structure-residence time relationships of macrocyclic Gαq protein inhibitors

Affiliations

Structure-affinity and structure-residence time relationships of macrocyclic Gαq protein inhibitors

Jan H Voss et al. iScience. .

Abstract

The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are potent inhibitors of Gαq/11 proteins. They are important pharmacological tools and have potential as therapeutic drugs. The hydrogenated, tritium-labeled YM and FR derivatives display largely different residence times despite similar structures. In the present study we established a competition-association binding assay to determine the dissociation kinetics of unlabeled Gq protein inhibitors. Structure-affinity and structure-residence time relationships were analyzed. Small structural modifications had a large impact on residence time. YM and FR exhibited 4- to 10-fold higher residence times than their hydrogenated derivatives. While FR showed pseudo-irreversible binding, YM displayed much faster dissociation from its target. The isopropyl anchor present in FR and some derivatives was essential for slow dissociation. These data provide a basis for future drug design toward modulating residence times of macrocyclic Gq protein inhibitors, which has been recognized as a crucial determinant for therapeutic outcome.

Keywords: Biochemistry; Biological sciences; Pharmacology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
Chemical structures, affinity values (pKi or pKD), and residence times (τ, in min) of FR, YM, and all characterized derivatives and analogs; n.d., not determined due to low affinity. The labeling position of the radioligands was highlighted in green
Figure 2
Figure 2
Binding experiments of [³H]PSB-15900 to Gαq proteins, expressed in HEK293 cell membranes (A) Saturation binding of [³H]PSB-15900 to HEK293-Gαq membranes (25 μg of protein). The following values were determined: pKD = 8.19 ± 0.16, Bmax = 27.5 ± 2.9 pmol/mg. (B) Association kinetics of [3H]PSB-15900 (5 nM) to HEK293-Gαq membrane preparations. The observed association rate kobs was 0.080 ± 0.006 min-1, resulting in an association half-life (ln 2/kobs) of 8.71 ± 0.60 min. (C) Dissociation kinetics of [3H]PSB-15900 to HEK293-Gαq membrane preparations. The dissociation rate koff was determined as 0.0078 ± 0.0005 min−1 resulting in a dissociation half-life (ln 2/koff) of 91.0 ± 5.4 min and a residence time (1/koff) of 131 ± 8 min. All data points represent means ± SD of three separate experiments, performed in duplicates.
Figure 3
Figure 3
Characterization of FR and YM derivatives in radioligand-binding assays versus [³H]PSB-15900 Competition-binding experiments of (A) FR and its derivatives, (B) YM and its derivatives YM-1, YM-3, YM-7, and YM-8, (C) YM and its derivatives YM-9 to YM-12, and (D) YM and its derivatives YM-13, YM-14, YM-15, and YM-18 versus [³H]PSB-15900. (E) pKi values of FR, YM, and all investigated derivatives as determined in competition-binding assays. For affinity values see Table 1. Significance levels were obtained from a one-way ANOVA with multiple comparisons (FR derivatives were compared to FR, YM derivatives were compared to YM) using Dunnett’s post-hoc test; p > 0.05 not significant (n.s.), p < 0.05 ∗; p < 0.01 ∗∗; p < 0.001 ∗∗∗. Data is represented as mean ± SD of three separate experiments, performed in duplicates. (F) Correlation of affinity data from competition-binding assays with functional data from previously performed IP1 assays; slope = 0.75, R2 = 0.89,20–22 an ideal line (slope = 1) is plotted in light gray for comparison.
Figure 4
Figure 4
Establishing competition-association binding assays (A) Competition-association binding assays with the FR-derived radioligand [³H]PSB-15900 at HEK293-Gαq membrane preparations (25 μg of protein per vial). (B–D) Competition-association binding assays of [³H]PSB-15900 versus the indicated competitor (B. FR, C. YM, D. YM-18) at 1-, 3-, and 10-fold of their IC50 value. The inhibitor-free association curve is displayed in light blue. (E) The correlation between competitor concentration of FR (red), YM (blue), and YM-18 (gray) and log koff as determined by the “Kinetics of competitive binding”-fit in Prism 8.4.0. All data are as means ± SD from 3 to 4 independent experiments performed in duplicates.
Figure 5
Figure 5
Competition-association assays for the determination of the residence time of Gαq inhibitors The curve of the indicated compound is shown in black, the curves of competitor-free [³H]PSB-15900 association are displayed in blue, and the curves of either FR (for FR-derived compounds) or YM (for YM-derived compounds) is displayed in gray for reference. A-D. Competition-association curves of FR derivatives (A. FR, B. FR-1, C. FR-2, D. FR-3/4). E-J. Competition-association curves of YM derivatives and analogs (E. YM, F. YM-10, G. YM-12, H. YM-13, I. YM-14, J. YM-18). All data are means ± SD of 3–4 independent experiments performed in duplicates.
Figure 6
Figure 6
Binding site of macrocyclic Gαq protein inhibitors and inhibitor-protein interactions (A) Binding site of YM (magenta) at the heterotrimeric Gαqβ1γ2 protein (Gαq cyan, Gβ1 light gray, Gγ2 dark gray) as determined by X-ray crystallography (PDB: 3AH8). Guanosine diphosphate is shown in yellow. A close-up illustrating the binding pose of YM, highlighting the amino acids Arg60 and Glu191, at the membrane is displayed at the right. (B) 2D-ligand interaction diagram of YM at the binding pocket of the Gαq protein, generated by Molecular Operating Environment (Chemical Computing Group, Cambridge, UK). See also Figures S1–S4 for ligand-binding site interactions of YM and FR derivatives.
Figure 7
Figure 7
Correlations between affinity (pKi) and kinetic rate constants obtained by competition-association binding assays Correlations (A) between affinity (pKi) and association rate (log kon), and (B) between affinity (pKi) and dissociation rate (log koff). The 95%-confidence interval is shown as dotted lines in (B).

Similar articles

Cited by

References

    1. Sprang S.R. Invited review: activation of G proteins by GTP and the mechanism of Gα-catalyzed GTP hydrolysis. Biopolymers. 2016;105:449–462. doi: 10.1002/bip.22836. - DOI - PMC - PubMed
    1. Oldham W.M., Hamm H.E. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 2008;9:60–71. doi: 10.1038/nrm2299. - DOI - PubMed
    1. Simon M.I., Strathmann M.P., Gautam N. Diversity of G proteins in signal transduction. Science. 1991;252:802–808. doi: 10.1126/science.1902986. - DOI - PubMed
    1. Voss J.H., Müller C.E. Heterotrimeric G protein Α-subunits - structures, peptide-derived inhibitors, and mechanisms. Curr. Med. Chem. 2022;29:6359–6378. doi: 10.2174/0929867329666220308112424. - DOI - PubMed
    1. Hauser A.S., Attwood M.M., Rask-Andersen M., Schiöth H.B., Gloriam D.E. Trends in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 2017;16:829–842. doi: 10.1038/nrd.2017.178. - DOI - PMC - PubMed

LinkOut - more resources